ArticleFrontiers in oncology2022

A New SteatoScore in the Evaluation of Non-Alcoholic Liver Disease in Oncologic Patients.

Dania Cioni et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.